Correlation Between Destination and BioNTech
Can any of the company-specific risk be diversified away by investing in both Destination and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Destination and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Destination XL Group and BioNTech SE, you can compare the effects of market volatilities on Destination and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Destination with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Destination and BioNTech.
Diversification Opportunities for Destination and BioNTech
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Destination and BioNTech is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Destination XL Group and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Destination is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Destination XL Group are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Destination i.e., Destination and BioNTech go up and down completely randomly.
Pair Corralation between Destination and BioNTech
Given the investment horizon of 90 days Destination XL Group is expected to generate 1.56 times more return on investment than BioNTech. However, Destination is 1.56 times more volatile than BioNTech SE. It trades about 0.01 of its potential returns per unit of risk. BioNTech SE is currently generating about -0.01 per unit of risk. If you would invest 281.00 in Destination XL Group on October 8, 2024 and sell it today you would lose (10.00) from holding Destination XL Group or give up 3.56% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Destination XL Group vs. BioNTech SE
Performance |
Timeline |
Destination XL Group |
BioNTech SE |
Destination and BioNTech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Destination and BioNTech
The main advantage of trading using opposite Destination and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Destination position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.Destination vs. Cato Corporation | Destination vs. Zumiez Inc | Destination vs. Tillys Inc | Destination vs. Duluth Holdings |
BioNTech vs. Novavax | BioNTech vs. Ginkgo Bioworks Holdings | BioNTech vs. Crispr Therapeutics AG | BioNTech vs. Ocean Biomedical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |